Cargando…

Ameliorating effect of probiotic on nonalcoholic fatty liver disease and lipolytic gene expression in rabbits

Nonalcoholic fatty liver disease (NAFLD) is a condition that affects about 24% of people worldwide. Increased liver fat, inflammation, and, in the most severe cases, cell death are all characteristics of NAFLD. However, NAFLD pathogenesis and therapy are still not clear enough. Thus, this study aime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aziz, Marina, Hemeda, Shabaan A., Albadrani, Ghadeer M., Fadl, Sabreen E., Elgendey, Fatma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113232/ https://www.ncbi.nlm.nih.gov/pubmed/37072469 http://dx.doi.org/10.1038/s41598-023-32584-7

Ejemplares similares

The impact of vitamin E and/or selenium dietary supplementation on growth parameters and expression levels of the growth-related genes in broilers
por: Khalifa, Olla A., et al.
Publicado: (2021)

Selenium and/or vitamin E upregulate the antioxidant gene expression and parameters in broilers
por: Elgendey, Fatma, et al.
Publicado: (2022)

Ameliorative effects of camel milk and silymarin upon aflatoxin B1 induced hepatic injury in rats
por: Hassaneen, Nahla H., et al.
Publicado: (2023)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease
por: Huang, Yuanshe, et al.
Publicado: (2022)

Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
por: Mijangos-Trejo, Alejandra, et al.
Publicado: (2023)

Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
por: Ren, Tian-Yi, et al.
Publicado: (2021)

Efficacy of probiotics on nonalcoholic fatty liver disease: A meta-analysis
por: Zhou, Xiangyu, et al.
Publicado: (2023)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

Recombinant Lactococcus lactis Expressing Ling Zhi 8 Protein Ameliorates Nonalcoholic Fatty Liver and Early Atherogenesis in Cholesterol-Fed Rabbits
por: Lee, Mey-Fann, et al.
Publicado: (2020)

DEMYELINIZATION INDUCED IN LIVING RABBITS BY MEANS OF A LIPOLYTIC ENZYME PREPARATION
por: Vogel, F. Stephen
Publicado: (1951)

Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis
por: S Lavekar, Anurag, et al.
Publicado: (2017)

Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease
por: Xiao, Meng-Wei, et al.
Publicado: (2019)

Novel predictors of early atherosclerosis in nonalcoholic fatty liver disease
por: Abdulaziz, Badawy Abdulkhalik, et al.
Publicado: (2023)

Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver Axis
por: Endo, Hitoshi, et al.
Publicado: (2013)

Impact of Dietary or Drinking Water Ruminococcus sp. Supplementation and/or Heat Stress on Growth, Histopathology, and Bursal Gene Expression of Broilers
por: Saad, Adel Hassan, et al.
Publicado: (2021)

THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEW
por: Chaves, Felipe Galvão Batista, et al.
Publicado: (2020)

The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies
por: Meroni, Marica, et al.
Publicado: (2019)

Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Tang, Yao, et al.
Publicado: (2019)

Health Effects of Probiotics on Nonalcoholic Fatty Liver in the Life Cycle Based on Data Analysis
por: Wang, Jia, et al.
Publicado: (2022)

The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Ndakotsu, Andrew, et al.
Publicado: (2022)

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
por: Zeybel, Mujdat, et al.
Publicado: (2021)

Isolation of novel Lactobacillus with lipolytic activity from the vinasse and their preliminary potential using as probiotics
por: Guan, Chengran, et al.
Publicado: (2020)

Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats
por: Li, Donghao, et al.
Publicado: (2017)

Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of O-GlcNAcylation
por: Lee, Da Eun, et al.
Publicado: (2019)

Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
por: Yang, Xiao-Fang, et al.
Publicado: (2021)

Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice
por: Ding, Jian, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation
por: Wu, You, et al.
Publicado: (2021)

Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model
por: Xu, Ren-ying, et al.
Publicado: (2012)

Deeper insight into maternal genetic assessments and demographic history for Egyptian indigenous chicken populations using mtDNA analysis
por: Eltanany, Marwa A., et al.
Publicado: (2016)

Innate immunity and nonalcoholic fatty liver disease
por: Kountouras, Jannis, et al.
Publicado: (2023)

Ameliorative Effects of Pomegranate Peel Extract against Dietary-Induced Nonalcoholic Fatty Liver in Rats
por: Al-Shaaibi, Siham N. K., et al.
Publicado: (2016)

Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice
por: Qian, Minyi, et al.
Publicado: (2019)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

Lanzhang Granules Ameliorate Nonalcoholic Fatty Liver Disease by Regulating the PPARα Signaling Pathway
por: Huang, Ping, et al.
Publicado: (2022)

Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model
por: Guzman, Stephania, et al.
Publicado: (2022)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
por: Chen, Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ipfcc27c6iagnrkoaitnn9cu99